Topic · Cervical Cancer and HPV Research
Most cited papers in Cervical Cancer and HPV Research
What are the most cited papers in Cervical Cancer and HPV Research?
The most cited paper in Cervical Cancer and HPV Research is "Global cancer statistics" (Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al., 2011), with 55,108 citations. Next come "Global Cancer Statistics, 2002" (18,430) and "Cancer statistics, 2023" (17,031).
Showing 50 of 100 papers. Every paper with more than 1,118 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Global cancer statistics Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians | 4 Feb 2011 | 55,108 |
| 2 | Global Cancer Statistics, 2002 Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians | Mar 2005 | 18,430 |
| 3 | Cancer statistics, 2023 Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle et al. · CA A Cancer Journal for Clinicians | 2023 | 17,031 |
| 4 | Cancer statistics, 2024 Rebecca L. Siegel, Angela N. Giaquinto, Ahmedin Jemal · CA A Cancer Journal for Clinicians | 2024 | 9,500 |
| 5 | Human papillomavirus is a necessary cause of invasive cervical cancer worldwide Jan M.M. Walboomers, Marcel V. Jacobs, M. Michele Manos et al. · The Journal of Pathology | Sep 1999 | 9,115 |
| 6 | Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer Núbia Muñóz, Francesc Xavier Bosch, Sílvia de Sanjosé et al. · New England Journal of Medicine | 5 Feb 2003 | 6,330 |
| 7 | Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis Marc Arbyn, Elisabete Weiderpass, Laia Bruni et al. · The Lancet Global Health | 4 Dec 2019 | 4,260 |
| 8 | Papillomaviruses and cancer: from basic studies to clinical application Harald zur Hausen · Nature reviews. Cancer | May 2002 | 4,062 |
| 9 | The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Martin Scheffner, Bruce A. Werness, Jon M. Huibregtse et al. · Cell | Dec 1990 | 4,034 |
| 10 | Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States Anil K. Chaturvedi, Eric A. Engels, Ruth M. Pfeiffer et al. · Journal of Clinical Oncology | 4 Oct 2011 | 3,651 |
| 11 | The causal relation between human papillomavirus and cervical cancer Francesc Xavier Bosch, Attila Tibor Lorincz, N Munoz et al. · Journal of Clinical Pathology | Apr 2002 | 3,609 |
| 12 | Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective Francesc Xavier Bosch, M. Michele Manos, N. Munoz et al. · JNCI Journal of the National Cancer Institute | 7 Jun 1995 | 3,439 |
| 13 | Classification of papillomaviruses Ethel-Michele de Villiers, Claude Fauquet, Thomas R. Broker et al. · Virology | 8 May 2004 | 3,233 |
| 14 | The 2001 Bethesda System Terminology for Reporting Results of Cervical Cytology Diane Solomon · JAMA | 24 Apr 2002 | 3,150 |
| 15 | Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers Maura L. Gillison · JNCI Journal of the National Cancer Institute | 3 May 2000 | 3,121 |
| 16 | Human papillomavirus and cervical cancer MARK H. SCHIFFMAN, Philip E. Castle, José Jerónimo et al. · The Lancet | Sep 2007 | 3,039 |
| 17 | Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium S. Pecorelli · International Journal of Gynecology & Obstetrics | 27 Mar 2009 | 2,914 |
| 18 | Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Silvia de Sanjosé et al. · The Lancet Oncology | 18 Oct 2010 | 2,774 |
| 19 | Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53 Bruce A. Werness, Arnold J. Levine, Peter M. Howley · Science | 6 Apr 1990 | 2,614 |
| 20 | Global burden of cancers attributable to infections in 2008: a review and synthetic analysis Catherine de Martel, Jacques Ferlay, Silvia Franceschi et al. · The Lancet Oncology | 8 May 2012 | 2,554 |
| 21 | Cervical cancer Paul Andrew Cohen, Anjua Jhingran, Ana Oaknin et al. · The Lancet | 2019 | 2,514 |
| 22 | Human Papillomavirus and Cervical Cancer Eileen M. Burd · Clinical Microbiology Reviews | 2003 | 2,452 |
| 23 | Worldwide burden of cancer attributable to HPV by site, country and HPV type Catherine de Martel, Martyn Plummer, Jérôme Vignat et al. · International Journal of Cancer | 4 Apr 2017 | 2,393 |
| 24 | Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix William A. Peters, P.Y. Liu, Rolland J. Barrett et al. · Journal of Clinical Oncology | 8 Apr 2000 | 2,338 |
| 25 | Natural History of Cervicovaginal Papillomavirus Infection in Young Women Gloria Y.F. Ho, Robert H. Bierman, Leah Beardsley et al. · New England Journal of Medicine | 12 Feb 1998 | 2,285 |
| 26 | The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi Jews Jeffery P. Struewing, Patricia A. Hartge, Sholom Wacholder et al. · New England Journal of Medicine | 15 May 1997 | 2,267 |
| 27 | Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022 John Patrick Thornhill et al. · New England Journal of Medicine | 21 Jul 2022 | 2,219 |
| 28 | Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review Aimée R. Kreimer, Gary M. Clifford, Peter A. Boyle et al. · Cancer Epidemiology Biomarkers & Prevention | Feb 2005 | 2,191 |
| 29 | A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Matthias Dürst, Lutz Gissmann, Hans Ikenberg et al. · Proceedings of the National Academy of Sciences | Jun 1983 | 2,040 |
| 30 | ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma Nicole Concin et al. · International Journal of Gynecological Cancer | 23 Dec 2020 | 2,012 |
| 31 | Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma Henry M. Keys, Brian N. Bundy, Frederick B. Stehman et al. · New England Journal of Medicine | 15 Apr 1999 | 1,955 |
| 32 | Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases Suzanne Marie Garland, Mauricio Hernández‐Ávila, Cosette Marie Wheeler et al. · New England Journal of Medicine | 9 May 2007 | 1,907 |
| 33 | Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials Guglielmo Ronco, Joakim Dillner, K. Miriam Elfström et al. · The Lancet | 2 Nov 2013 | 1,845 |
| 34 | HPV-associated head and neck cancer: a virus-related cancer epidemic Shanthi Marur, Gypsyamber DʼSouza, William H. Westra et al. · The Lancet Oncology | 6 May 2010 | 1,839 |
| 35 | The Epidemiology of Osteosarcoma Giulia Ottaviani, Norman Jaffe · Cancer treatment and research | 2009 | 1,825 |
| 36 | Human papillomavirus oncoproteins: pathways to transformation Cary A. Moody, Laimonis A. Laimins · Nature reviews. Cancer | Jul 2010 | 1,779 |
| 37 | Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update Jennifer Susan Smith, Lisa Lindsay, Brooke Hoots et al. · International Journal of Cancer | 2 Apr 2007 | 1,695 |
| 38 | Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis Silvia de Sanjosé, Mireia Díaz, Xavier Castellsagué et al. · The Lancet Infectious Diseases | 26 Jun 2007 | 1,693 |
| 39 | Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments Hans-Ulrich Bernard, Robert David Burk, Zigui Chen et al. · Virology | 8 Mar 2010 | 1,675 |
| 40 | Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings Laia Bruni, Mireia Díaz, Xavier Castellsagué et al. · The Journal of Infectious Diseases | 10 Nov 2010 | 1,666 |
| 41 | Global Burden of Human Papillomavirus and Related Diseases David Forman, Catherine de Martel, Charles J. Lacey et al. · Vaccine | Nov 2012 | 1,664 |
| 42 | Global burden of cancers attributable to infections in 2012: a synthetic analysis Martyn Plummer, Catherine de Martel, Jérôme Vignat et al. · The Lancet Global Health | 26 Jul 2016 | 1,663 |
| 43 | Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women Jorma A. Paavonen et al. · The Lancet | Jul 2009 | 1,663 |
| 44 | Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial Diane Medved Harper, Eduardo Luis Franco, Cosette Marie Wheeler et al. · The Lancet | Nov 2004 | 1,648 |
| 45 | Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial Diane Medved Harper, Eduardo Luis Franco, Cosette Marie Wheeler et al. · The Lancet | Apr 2006 | 1,642 |
| 46 | Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative Deependra Singh, Jérôme Vignat, Valentina Lorenzoni et al. · The Lancet Global Health | 14 Dec 2022 | 1,632 |
| 47 | Integrated genomic and molecular characterization of cervical cancer Robert D. Burk et al. · Nature | 20 Jan 2017 | 1,631 |
| 48 | A Controlled Trial of a Human Papillomavirus Type 16 Vaccine Laura A. Koutsky, Kevin A. Ault, Cosette Marie Wheeler et al. · New England Journal of Medicine | 20 Nov 2002 | 1,615 |
| 49 | Prevalence of HPV Infection Among Females in the United States Eileen Frances Dunne, Elizabeth R. Unger, Maya Sternberg et al. · JAMA | 27 Feb 2007 | 1,601 |
| 50 | Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States Anil K. Chaturvedi, Eric A. Engels, William F. Anderson et al. · Journal of Clinical Oncology | 30 Jan 2008 | 1,591 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.